WATERTOWN, Mass. (AP) _ Enanta Pharmaceuticals Inc. (ENTA) on Wednesday reported fiscal first-quarter net income of $26 million.
The Watertown, Massachusetts-based company said it had net income of $1.25 per share.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.46 per share.
The biotechnology company posted revenue of $69.9 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $73.1 million.
Enanta Pharmaceuticals shares have risen 19 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $84.01, a fall of roughly 9 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENTA at https://www.zacks.com/ap/ENTA